Natco Pharma reports over 3-fold rise in net profit at Rs 212.7 crore in Q3 Ruchika Sharma15 Feb 2024 7:00 AMHyderabad: Natco Pharma Ltd has reported over three-fold rise in consolidated net profit at Rs 212.7 crore in the third quarter ended December...
Zydus Lifesciences reports bigger-than-expected rise in Q3 profit Ruchika Sharma11 Feb 2024 4:30 AMBengaluru: Indian generic drugmaker Zydus Lifesciences reported a bigger-than-expected rise in third-quarter profit, driven by strong sales in its...
Abbott India profit rises in Q3 on strong demand Ruchika Sharma2 Feb 2024 4:30 AMBengaluru: Pharmaceutical firm Abbott India reported a 26 percent rise in third-quarter profit on Thursday, as higher sales outpaced the impact...
Lupin reports 72 percent decline in consolidated net profit at Rs 153 crore for Q3 Ruchika Sharma11 Feb 2023 3:30 AMNew Delhi: Drug maker Lupin has reported 72 percent decline in consolidated net profit at Rs 153 crore for the third quarter ended December 31,...
Piramal Pharma reports consolidated net loss of Rs 90 crore in Q3 Ruchika Sharma10 Feb 2023 7:45 AMNew Delhi: Piramal Pharma has reported a net loss of Rs 90 crore on a consolidated basis for the third quarter ended December 31, 2022. The...
Alembic Pharma beats estimates on higher domestic sales Ruchika Sharma2 Feb 2023 8:45 AMConsolidated revenue from operations for the company rose nearly 19 percent from last year.
Strides Pharma posts consolidated net loss at Rs 82 crore in Q3 Ruchika Sharma26 Jan 2023 8:30 AMNew Delhi: Strides Pharma Science has reported a consolidated net loss of Rs 82 crore for the third quarter ended December 31, 2022.The drug firm had...
Gland Pharma net profit declines 15 percent to Rs 232 crore in Q3 Ruchika Sharma26 Jan 2023 4:30 AMDuring the quarter, total R&D expense stood at Rs 51.2 crore, at 5.5 percent of revenue, the company said, adding the total capex incurred during the...
Granules India reports 23 percent rise in Q3 profit Ruchika Sharma25 Jan 2023 9:45 AMGranules, which also makes anti-inflammatory drug Ibuprofen, said 45.6 percent of its revenue came from finished dosages, the final...
Glenmark Pharma reports revenue growth of 13.9 percent in Q3 Ruchika Sharma13 Feb 2022 4:00 AMMumbai: Glenmark Pharmaceuticals Limited, a global innovation-driven pharmaceutical company, has announced its financial results for the third...
Lincoln Pharma reports over 30 percent rise in net profit in Q3 Ruchika Sharma11 Feb 2022 3:30 AMAhmedabad: Leading healthcare company Gujarat based Lincoln Pharmaceuticals Ltd has reported a net profit of Rs. 17.60 crore for the Q3 FY22 ended...
Lupin net profit up 24 percent at Rs 545 crore in Q3 Ruchika Sharma7 Feb 2022 4:30 AMNew Delhi: Drugmaker Lupin on Friday reported a 24.45 per cent rise in its consolidated net profit at Rs 545.5 crore for the third quarter ended...
